{"id":782371,"date":"2023-09-07T06:04:23","date_gmt":"2023-09-07T10:04:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/"},"modified":"2023-09-07T06:04:23","modified_gmt":"2023-09-07T10:04:23","slug":"adagene-to-present-at-investor-and-scientific-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/","title":{"rendered":"Adagene to Present at Investor and Scientific Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>\u2013 Adagene\u2019s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies \u2013<\/em>\n      <\/p>\n<p>SAN DIEGO and SUZHOU, China, Sept.  07, 2023  (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the company\u2019s participation in several upcoming investor and scientific conferences.<\/p>\n<p>Adagene\u2019s management will review recent clinical data demonstrating the best-in-class safety and efficacy profile for its masked anti-CTLA-4 candidate, ADG126. Details include:<\/p>\n<p>\n        <strong>Morgan Stanley 21st Annual Global Healthcare Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Date:<\/strong> Monday, September 11, 2023<\/li>\n<li>\n          <strong>Fireside Chat Time:<\/strong> 4:15 PM-4:45 PM ET<\/li>\n<li>Management will participate in investor meetings and a Fireside Chat, for which a live audio webcast and replay will be accessible in the Investors section of the company\u2019s website <a href=\"https:\/\/investor.adagene.com\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>.<\/li>\n<\/ul>\n<p>\n        <strong>H.C. Wainwright 25th Annual Global Investment Conference <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Date: <\/strong>Wednesday, September 13, 2023<\/li>\n<li>\n          <strong>Fireside Chat Time: <\/strong>12:00 PM-12:30 PM ET<\/li>\n<li>Management will participate in investor meetings and a Fireside Chat during the conference.<\/li>\n<\/ul>\n<p>\n        <strong>Society for Immunotherapy of Cancer (SITC) Webinar \u201cModulation of Tregs in Clinical Trials\u201d <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Date: <\/strong>Friday, September 22, 2023<\/li>\n<li>\n          <strong>Presentation Time: <\/strong>12:00 PM-2:00 PM ET<\/li>\n<li>Featuring a group of distinguished speakers, this webinar will focus on CTLA-4 mediated regulatory T cells (Tregs) and their essential role in anti-cancer therapy. Part of the series \u201cTargets for Cancer IO: A Deep Dive,\u201d the full agenda and registration details are available <a href=\"https:\/\/www.sitcancer.org\/education\/webinars-online\/cancer-io-deep-dive\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>.<\/li>\n<\/ul>\n<p>\n        <strong>About\u00a0Adagene<\/strong><br \/>\n        <br \/>Adagene Inc.\u00a0(Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.\u00a0Adagene\u00a0combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary\u00a0Dynamic Precision Library\u00a0(DPL) platform, composed of NEObody\u2122, SAFEbody<sup>\u00ae<\/sup>, and POWERbody\u2122 technologies, Adagene\u2019s highly differentiated pipeline features novel immunotherapy programs.\u00a0Adagene\u00a0has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.<\/p>\n<p>For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2Ii67HnNrG-hBTNIV793bd9G7e8lgGq_0Eq2totUT8RC9kr1-CIGD7aot47tRAAi5spcqCPbYByFaxQsMjBceJ_HLKs-s5SZ98CSoqLZIM0UNbo62w-aWAOSCYviiXVN\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investor.adagene.com<\/a>. Follow\u00a0Adagene\u00a0on WeChat, LinkedIn and Twitter.<\/p>\n<p>SAFEbody<sup>\u00ae<\/sup>\u00a0is a registered trademark in\u00a0the United States,\u00a0China,\u00a0Australia,\u00a0Japan,\u00a0Singapore, and the\u00a0European Union.<\/p>\n<p>\n        <strong>Investor &amp; Media Contact<\/strong><br \/>\n        <br \/>Ami Knoefler<br \/>Adagene<br \/>650-739-9952<br \/>ir@adagene.com<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTg2NmE4NDktNTM1My00MDgyLTkwMzQtZTQzMjkyMzQzMTI5LTEyMTYyMzQ=\/tiny\/Adagene-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2013 Adagene\u2019s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies \u2013 SAN DIEGO and SUZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the company\u2019s participation in several upcoming investor and scientific conferences. Adagene\u2019s management will review recent clinical data demonstrating the best-in-class safety and efficacy profile for its masked anti-CTLA-4 candidate, ADG126. Details include: Morgan Stanley 21st Annual Global Healthcare Conference Date: Monday, September 11, 2023 Fireside Chat Time: 4:15 PM-4:45 PM ET Management will participate in investor meetings and a Fireside Chat, for which a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adagene to Present at Investor and Scientific Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-782371","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"\u2013 Adagene\u2019s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies \u2013 SAN DIEGO and SUZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the company\u2019s participation in several upcoming investor and scientific conferences. Adagene\u2019s management will review recent clinical data demonstrating the best-in-class safety and efficacy profile for its masked anti-CTLA-4 candidate, ADG126. Details include: Morgan Stanley 21st Annual Global Healthcare Conference Date: Monday, September 11, 2023 Fireside Chat Time: 4:15 PM-4:45 PM ET Management will participate in investor meetings and a Fireside Chat, for which a &hellip; Continue reading &quot;Adagene to Present at Investor and Scientific Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-07T10:04:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adagene to Present at Investor and Scientific Conferences in September\",\"datePublished\":\"2023-09-07T10:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/\"},\"wordCount\":368,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/\",\"name\":\"Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\",\"datePublished\":\"2023-09-07T10:04:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adagene-to-present-at-investor-and-scientific-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adagene to Present at Investor and Scientific Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk","og_description":"\u2013 Adagene\u2019s CEO, Dr. Peter Luo, participating in SITC webinar on September 22 focused on essential role of Treg depletion for anti-CTLA-4 therapies \u2013 SAN DIEGO and SUZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) &#8212; Adagene Inc. (\u201cAdagene\u201d) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the company\u2019s participation in several upcoming investor and scientific conferences. Adagene\u2019s management will review recent clinical data demonstrating the best-in-class safety and efficacy profile for its masked anti-CTLA-4 candidate, ADG126. Details include: Morgan Stanley 21st Annual Global Healthcare Conference Date: Monday, September 11, 2023 Fireside Chat Time: 4:15 PM-4:45 PM ET Management will participate in investor meetings and a Fireside Chat, for which a &hellip; Continue reading \"Adagene to Present at Investor and Scientific Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-07T10:04:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adagene to Present at Investor and Scientific Conferences in September","datePublished":"2023-09-07T10:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/"},"wordCount":368,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/","name":"Adagene to Present at Investor and Scientific Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=","datePublished":"2023-09-07T10:04:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxODE4OCM1ODAzMDQ2IzIyMDQ2ODE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adagene-to-present-at-investor-and-scientific-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adagene to Present at Investor and Scientific Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=782371"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/782371\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=782371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=782371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=782371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}